Pasar al contenido principal

RED TRASLACIONAL PARA LA APLICACION CLINICA DE VESICULAS EXTRACELULARES

RED2018-102411-T

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Redes Investigación /Redes Excelencia
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD AUTONOMA DE MADRID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Comparative profiling of whole-cell and exosome samples reveals protein signatures that stratify breast cancer subtypes

  • Andreu, Zoraida
  • Hidalgo, Marta R.
  • Masia, Esther
  • Romera-Giner, Sergio
  • Malmierca-Merlo, Pablo
  • López-Guerrero, José A.
  • García-García, Francisco
  • Vicent, María J.
[EN] Identifying novel breast cancer biomarkers will improve patient stratification, enhance therapeutic outcomes, and help develop non-invasive diagnostics. We compared the proteomic profiles of whole-cell and exosomal samples of representative breast cancer cell subtypes to evaluate the potential of extracellular vesicles as non-invasive disease biomarkers in liquid biopsies. Overall, differentially-expressed proteins in whole-cell and exosome samples (which included markers for invasion, metastasis, angiogenesis, and drug resistance) effectively discriminated subtypes; furthermore, our results confirmed that the proteomic profile of exosomes reflects breast cancer cell-of-origin, which underscores their potential as disease biomarkers. Our study will contribute to identifying biomarkers that support breast cancer patient stratification and developing novel therapeutic strategies. We include an open, interactive web tool to explore the data as a molecular resource that can explain the role of these protein signatures in breast cancer classification., This study was supported by the European Research Council (grant ERC-CoG-2014-648831 MyNano ) and the H2020 EU-OpenScreen-Drive project (grant agreement No. 823893). Our screening platform is part of the European Infrastructure, ERIC EUOpenScreen, and the Excellence Network, TeNTaCLES (Translational NeTwork for the CLinical application of Extracellular Vesicle-Tentacles-RED2018-102411-T). This research was also supported by the Spanish Ministry of Science and Innovation (PID2019-108806RBI00; PID2020-117211GB-I00; PID2021-124430OA-I00 funded by MICIU/AEI/https://doi.org/10.13039/501100011033 and by FEDER, UE; and partially funded by the Institute of Health Carlos III (project IMPaCT-Data, IMP/00019), co-funded by ERDF and CIBERONC (project n. CB22/12/00048). The proteomic analysis was performed in the proteomics facility of SCSIE University of Valencia, which belongs to ProteoRed, PRB2-ISCIII, supported by grant PT13/0001. Agreement 2019 between IVO and the Association Mou-te per elles.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Identification of the first cases of complete CD16A deficiency: Association with persistent EBV infection

  • Pérez-Portilla, A.
  • Moraru, M.
  • Blázquez Moreno, Alfonso
  • Kolb, Philipp
  • García-Morato, María Bravo
  • Ranganath, Thanmayi
  • Esteso, Gloria
  • Gianelli, Carla
  • Rodríguez-Pena, Rebeca
  • Lozano-Rodríguez, Roberto
  • Torres-Canizales, Juan Manuel
  • Blish, Catherine A.
  • Valés-Gómez, Mar
  • Hengel, Hartmut
  • Vilches, Carlos
  • López-Granados, Eduardo
  • Reyburn, H. T.
During the clinical workup of an adolescent male with chronic active EBV disease, it was noted that natural killer (NK) cells of this individual did not express the Fc-receptor CD16A (Fig 1, A). The index patient, born to nonconsanguineous parents, was first seen when he was 11 years old, and an extended workup revealed persistently high levels of EBV-encoded small RNA (EBER) DNA in peripheral blood and multiple-organ infiltration with EBV-positive T lymphocytes including an IgA- and EBV-positive interstitial nephritis that eventually led to renal failure (see Case Report and Table E1 in this article’s Online Repository at www.jacionline.org)., This work was supported by grants SAF2014-58752-R and SAF2017-83265-R to H.T.R. and grant SAF2016-80363-C2-2-R to C.V. (Spanish Science agency/European Regional Development Fund, European Union, AEI/FEDER, EU). The group of M.V.-G. has also received funding from the Spanish Ministry of Science and Innovation (grant nos. RTC-2017-6379-1 and RTI2018-093569-B-I00 [MCIU/AEI/FEDER, EU]) and the regional government of Madrid (grant no. S2017/BMD-3733-2). The group of M.V.-G. also belongs to the research network TENTACLES (RED2018-102411-T) funded by the Spanish Ministry of Science. A.P.P. and A.B.M. acknowledge PhD studentships funded by the National Secretary of Higher Education, Science, Technology and Innovation (SENESCYT, Ecuador) and Spanish Ministry of Economy and Competitivity (MINECO), respectively (SVP-2014-068263). M.M. was supported by grant GCB15152947MELE from Fundación de la Asociación Española contra el Cáncer. Work in the laboratory of H.H. is supported by Infect-ERA grant TANKACY, BMBF 031L0090, and German Research Foundation (DFG) grant HE2526/9-1. E.L.G. has grants from the Spanish Association Against Cancer (AECC) and Carlos III Health Institute (grant no. PI16/01605). C.A.B. acknowledges support from the National Institutes of Health (grant no. DP2AI11219301).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A simple immunoassay for extracellular vesicle liquid biopsy in microliters of non-processed plasma

  • Campos-Silva, Carmen
  • Cáceres-Martell, Yaiza
  • Sánchez-Herrero, Estela
  • Sandúa, Amaia
  • Beneítez-Martínez, Alexandra
  • González, Álvaro
  • Provencio, Mariano
  • Romero, Atocha
  • Jara-Acevedo, Ricardo
  • Yáñez-Mó, María
  • Valés-Gómez, Mar
[Background]: Extracellular vesicles (EVs), released by most cell types, provide an excellent source of biomarkers in biological fluids. However, in order to perform validation studies and screenings of patient samples, it is still necessary to develop general techniques permitting rapid handling of small amounts of biological samples from large numbers of donors., [Results]: Here we describe a method that, using just a few microliters of patient’s plasma, identifies tumour markers exposed on EVs. Studying physico-chemical properties of EVs in solution, we demonstrate that they behave as stable colloidal suspensions and therefore, in immunocapture assays, many of them are unable to interact with a stationary functionalised surface. Using flocculation methods, like those used to destabilize colloids, we demonstrate that cationic polymers increase EV ζ-potential, diameter, and sedimentation coefficient and thus, allow a more efficient capture on antibody-coated surfaces by both ELISA and bead-assisted flow cytometry. These findings led to optimization of a protocol in microtiter plates allowing effective immunocapture of EVs, directly in plasma without previous ultracentrifugation or other EV enrichment. The method, easily adaptable to any laboratory, has been validated using plasma from lung cancer patients in which the epithelial cell marker EpCAM has been detected on EVs., [Conclusions]: This optimized high throughput, easy to automate, technology allows screening of large numbers of patients to phenotype tumour markers in circulating EVs, breaking barriers for the validation of proposed EV biomarkers and the discovery of new ones., This work was supported by the Spanish Ministry of Science and Innovation (MCIU/AEI/FEDER, EU) under Grants RTI2018-093569-B-I00 and RED2018-102411-T (Translational Network for clinical application of EV, Tentacles); Madrid Regional Government under Grant “IMMUNOTHERCAN” (S2017/BMD-3733-2) and IND2019/BMD-17258., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

MAPK inhibitors dynamically affect melanoma release of immune NKG2D-ligands, as soluble protein and extracellular vesicle-associated

  • López-Borrego, Silvia
  • Campos-Silva, Carmen
  • Sandúa, Amaia
  • Camino, Tamara
  • Téllez-Pérez, Lucía
  • Alegre, Estibaliz
  • Beneítez-Martínez, Alexandra
  • Jara-Acevedo, Ricardo
  • Paschen, Annette
  • Pardo, María
  • González, Álvaro
  • Valés-Gómez, Mar
Metastatic melanoma presents, in many cases, oncogenic mutations in BRAF, a MAPK involved in proliferation of tumour cells. BRAF inhibitors, used as therapy in patients with these mutations, often lead to tumour resistance and, thus, the use of MEK inhibitors was introduced in clinics. BRAFi/MEKi, a combination that has modestly increased overall survival in patients, has been proven to differentially affect immune ligands, such as NKG2D-ligands, in drug-sensitive vs. drug-resistant cells. However, the fact that NKG2D-ligands can be released as soluble molecules or in extracellular vesicles represents an additional level of complexity that has not been explored. Here we demonstrate that inhibition of MAPK using MEKi, and the combination of BRAFi with MEKi in vitro, modulates NKG2D-ligands in BRAF-mutant and WT melanoma cells, together with other NK activating ligands. These observations reinforce a role of the immune system in the generation of resistance to directed therapies and support the potential benefit of MAPK inhibition in combination with immunotherapies. Both soluble and EV-associated NKG2D-ligands, generally decreased in BRAF-mutant melanoma cell supernatants after MAPKi in vitro, replicating cell surface expression. Because potential NKG2D-ligand fluctuation during MAPKi treatment could have different consequences for the immune response, a pilot study to measure NKG2D-ligand variation in plasma or serum from metastatic melanoma patients, at different time points during MAPKi treatment, was performed. Not all NKG2D-ligands were equally detected. Further, EV detection did not parallel soluble protein. Altogether, our data confirm the heterogeneity between melanoma lesions, and suggest testing several NKG2D-ligands and other melanoma antigens in serum, both as soluble or vesicle-released proteins, to help classifying immune competence of patients., This work was supported by a grant from the Spanish Ministry of Science and Innovation (PID2021-123795OB-I00 (MCIU/AEI/FEDER, EU). SLB and TC are recipients of fellowships from the Spanish Ministry of Education (FPU20/07300 and FPU17/02348 respectively). The group of MVG belongs to the research networks “Red Traslacional para la aplicacion clinica de vesiculas extracelulares” (Tentacles), RED 2018-102411-T and “Conexion cancer”-CSIC. CCS and SLB are registered PhD students at the Molecular Biosciences doctoral program of the Universidad Autónoma de Madrid (UAM). CCS received travel funding from Tentacles and GEIVEX (Grupo Español para la Investigación en Vesículas Extracelulares) to work in MP’s laboratory, Santiago de Compostela., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Phloem sap from melon plants contains extracellular vesicles that carry active proteasomes which increase in response to aphid infestation

  • Sánchez-López, Christian M.
  • Soler, Carla
  • Garzo, E.
  • Fereres, Alberto
  • Pérez-Bermúdez, Pedro
  • Marcilla, Antonio
The morphogenesis of higher plants requires communication among distant organs throughout vascular tissues (xylem and phloem). Numerous investigations have demonstrated that phloem also act as a distribution route for signalling molecules being observed that different macromolecules translocated by the sap, including nucleic acids and proteins, change under stress situations. The participation of extracellular vesicles (EVs) in this communication has been suggested, although little is known about their role. In fact, in the last decade, the presence of EVs in plants has originated a great controversy, where major concerns arose from their origin, isolation methods, and even the appropriate nomenclature for plant nanovesicles. Phloem sap exudates from melon plants, either aphid-free or infested with Aphis gossypii, were collected by stem incision. After sap concentration (Amicon), phloem EVs (PhlEVs) were isolated by size exclusion chromatography. PhlEVs were characterised using Nanoparticle Tracking Analysis, Transmission electron microscopy and proteomic analysis. Here we confirm the presence of EVs in phloem sap in vivo and the detection of changes in the particles/protein ratio and composition of PhlEVs in response to insect feeding, revealing the presence of typical defence proteins in their cargo as well as components of the proteasome complex. PhlEVs from infested plants showed lower particles/protein ratio and almost two times more proteolytic activity than PhlEVs from aphid-free plants. In both cases, such activity was inhibited in a dose-dependent manner by the proteasome inhibitor MG132. Our results suggest that plants may use this mechanism to prepare themselves to receive infectious agents and open up the possibility of an evolutionary conserved mechanism of defence against pathogens/stresses in eukaryotic organisms., The authors thank Mario Soriano (CIPF, Valencia, Spain) for processing samples for immuno-gold staining, and the Servicio Central Soporte a Investigación Experimental (SCSIE), Universitat de València for its support in Electronic Microscopy and Proteomics. This work was supported by the Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación, Spain (Grant numbers PID2019-105713GB-I00 and PID2023-146116NB-I00 and ERDF/EU), and the CSIC intramural project (201440E0169) “Papel de las vesículas extracelulares en los mecanismos de defensa de las plantas frente a insectos vectores de patógenos”. C.M.S-L is the recipient of a postdoctoral fellowship (PRE2020-092458) funded by AEI /10.13039/501100011033. Part of the “Red Traslacional para la Aplicación Clínica de Vesículas Extracelulares, Tentacles”, (RED2018-102411-T, Agencia Estatal de Investigación, Spain)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Polarized sorting of Patched enables cytoneme‐mediated Hedgehog reception in the Drosophila wing disc

  • González-Méndez, Laura
  • Gradilla, Ana-Citlali
  • Sánchez-Hernández, David
  • González, Esperanza
  • Aguirre-Tamaral, Adrián
  • Jiménez-Jiménez, Carlos
  • Guerra, Milagros
  • Aguilar, Gustavo
  • Andrés, Germán
  • Falcón-Pérez, Juan M.
  • Guerrero Vega, Isabel
El artículo fue portada de la revista., CSIC - Centro de Investigación en Sanidad Animal (CISA-INIA)., Hedgehog (Hh) signal molecules play a fundamental role in development, adult stem cell maintenance and cancer. Hh can signal at a distance, and we have proposed that its graded distribution across Drosophila epithelia is mediated by filopodia‐like structures called cytonemes. Hh reception by Patched (Ptc) happens at discrete sites along presenting and receiving cytonemes, reminiscent of synaptic processes. Here, we show that a vesicle fusion mechanism mediated by SNARE proteins is required for Ptc placement at contact sites. Transport of Ptc to these sites requires multivesicular bodies (MVBs) formation via ESCRT machinery, in a manner different to that regulating Ptc/Hh lysosomal degradation after reception. These MVBs include extracellular vesicle (EV) markers and, accordingly, Ptc is detected in the purified exosomal fraction from cultured cells. Blockage of Ptc trafficking and fusion to basolateral membranes result in low levels of Ptc presentation for reception, causing an extended and flattened Hh gradient., We are grateful to Pedro Ripoll and Robert Wilson for editing and comments on the manuscript. We are also thankful to the Proteomic Facility of the University of Bristol, especially to Kate Heesom, for their kind services towards proteomics analysis, to Michèle Crozatier for the α‐Col antibody, to Bob Holmgren for the α‐Ci antibody and to Tom Kornberg for the Hh‐GFP Bac and Ptc‐RFP Bac transgenic lines. Work was supported by grants BFU2015‐72831‐EXP and BFU2017‐83789‐P to IG, REDiEX consortium SAF2015‐71231‐REDT and RED2018‐102411‐T to JMF and IG and BFU2015‐73609‐JIN to ACG, all from the Spanish Ministry of Science, Innovation and University by institutional grants from the Fundación Areces and from Banco de Santander to the CBMSO. Germán Andrés was supported by the Amarouto Program for senior scientists from the Comunidad de Madrid., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Natural killer anti-tumor activity can be achieved by in vitro incubation with heat-killed BCG

  • Esteso, G.
  • Aguiló, N.
  • Julián, E.
  • Ashiru, O.
  • Ho, M. M.
  • Martin, C.
  • Vales-Gomez, M.
Natural Killer cell receptors allow this heterogeneous immune population to efficiently fight both tumors and infection, so their use as immunotherapy agents is an active field of research. Cytokine activation, particularly by myeloid cell-derived IL15, can induce potent NK anti-tumor responses. While studying the mechanism of action of intravesical instillations of Bacille Calmette-Guerin (BCG) as therapy for patients with high risk non-muscle invasive bladder cancer, we showed that BCG can activate a cytotoxic CD56(bright) NK cell population which efficiently recognized bladder cancer cells. This pioneer immunotherapy provides an invaluable model to understand the role of different immune populations in tumor elimination. However, during the propagation of BCG worldwide a large number of genetically diverse BCG substrains developed. Here, we investigated the capacity of different BCG substrains to promote NK cell activation and confirmed that they were able to activate lymphocytes. Tice, Connaught and Moreau were the substrains with a stronger NK activation effect as measured by CD56 upregulation. Surprisingly, dead mycobacteria also stimulated PBMC cultures and we further demonstrate here that subcellular fractions of BCG-Tice, in the absence of live mycobacteria, could also induce an NK cell response. Lipids from BCG-Tice, but not from Mycobacterium bovis, stimulated NK cell activation and degranulation, whereas the aqueous fraction of either bacteria did not activate lymphocytes. However, delipidated BCG-Tice bacteria were able to activate effector cells (CD3(+)CD56(+) and NK, CD3(-)CD56(+)). These data demonstrate that different components of mycobacteria can stimulate different immune subpopulations resulting in phenotypes suitable for cancer elimination.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Natural Killer Anti-Tumor Activity Can Be Achieved by In Vitro Incubation With Heat-Killed BCG

  • Esteso, Gloria
  • Aguiló, Nacho
  • Julián, Esther|||0000-0002-6558-3978
  • Ashiru, Omodele
  • Ho, Mei. M.
  • Martín, Carlos
  • Váles-Gómez, Mar|||0000-0001-7424-3206
Natural Killer cell receptors allow this heterogeneous immune population to efficiently fight both tumors and infection, so their use as immunotherapy agents is an active field of research. Cytokine activation, particularly by myeloid cell-derived IL15, can induce potent NK anti-tumor responses. While studying the mechanism of action of intravesical instillations of Bacille Calmette-Guérin (BCG) as therapy for patients with high risk non-muscle invasive bladder cancer, we showed that BCG can activate a cytotoxic CD56 bright NK cell population which efficiently recognized bladder cancer cells. This pioneer immunotherapy provides an invaluable model to understand the role of different immune populations in tumor elimination. However, during the propagation of BCG worldwide a large number of genetically diverse BCG substrains developed. Here, we investigated the capacity of different BCG substrains to promote NK cell activation and confirmed that they were able to activate lymphocytes. Tice, Connaught and Moreau were the substrains with a stronger NK activation effect as measured by CD56 upregulation. Surprisingly, dead mycobacteria also stimulated PBMC cultures and we further demonstrate here that subcellular fractions of BCG-Tice, in the absence of live mycobacteria, could also induce an NK cell response. Lipids from BCG-Tice, but not from Mycobacterium bovis, stimulated NK cell activation and degranulation, whereas the aqueous fraction of either bacteria did not activate lymphocytes. However, delipidated BCG-Tice bacteria were able to activate effector cells (CD3 + CD56 + and NK, CD3 - CD56 +). These data demonstrate that different components of mycobacteria can stimulate different immune subpopulations resulting in phenotypes suitable for cancer elimination.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

N-Glycans in Immortalized Mesenchymal Stromal Cell-Derived Extracellular Vesicles Are Critical for EV-Cell Interaction and Functional Activation of Endothelial Cells

  • Clos Sansalvador, Marta|||0000-0001-8522-7818
  • Garcia, Sergio G.|||0000-0001-7698-3734
  • Font-Morón, Miriam|||0000-0002-4714-252X
  • Williams, Charles
  • Reichardt, Niels-Christian
  • Falcón-Pérez, Juan M.|||0000-0003-3133-0670
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Roura, Santiago|||0000-0003-4063-9661
  • Franquesa, Marcella|||0000-0002-1287-8908
  • Monguió-Tortajada, Marta|||0000-0003-2125-0810
  • Borràs i Serres, Francesc Enric|||0000-0003-4038-1912
Mesenchymal stromal cell-derived extracellular vesicles (MSC-EV) are widely considered as a cell-free therapeutic alternative to MSC cell administration, due to their immunomodulatory and regenerative properties. However, the interaction mechanisms between EV and target cells are not fully understood. The surface glycans could be key players in EV-cell communication, being specific molecular recognition patterns that are still little explored. In this study, we focused on the role of N-glycosylation of MSC-EV as mediators of MSC-EV and endothelial cells' interaction for subsequent EV uptake and the induction of cell migration and angiogenesis. For that, EV from immortalized Wharton's Jelly MSC (iWJ-MSC-EV) were isolated by size exclusion chromatography (SEC) and treated with the glycosidase PNGase-F in order to remove wild-type N-glycans. Then, CFSE-labelled iWJ-MSC-EV were tested in the context of in vitro capture, agarose-spot migration and matrigel-based tube formation assays, using HUVEC. As a result, we found that the N-glycosylation in iWJ-MSC-EV is critical for interaction with HUVEC cells. iWJ-MSC-EV were captured by HUVEC, stimulating their tube-like formation ability and promoting their recruitment. Conversely, the removal of N-glycans through PNGase-F treatment reduced all of these functional activities induced by native iWJ-MSC-EV. Finally, comparative lectin arrays of iWJ-MSC-EV and PNGase-F-treated iWJ-MSC-EV found marked differences in the surface glycosylation pattern, particularly in N-acetylglucosamine, mannose, and fucose-binding lectins. Taken together, our results highlight the importance of N-glycans in MSC-EV to permit EV-cell interactions and associated functions.